Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar.
Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar.
Rev Med Virol. 2021 Jul;31(4):e2196. doi: 10.1002/rmv.2196. Epub 2020 Nov 18.
The current severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) outbreak has been rapidly spreading worldwide, causing serious global concern. The role that animal hosts play in disease transmission is still understudied and researchers wish to find suitable animal models for fundamental research and drug discovery. In this systematic review, we aimed to compile and discuss all articles that describe experimental or natural infections with SARS-CoV-2, from the initial discovery of the virus in December 2019 through to October 2020. We systematically searched four databases (Scopus, PubMed, Science Direct and Web of Science). The following data were extracted from the included studies: type of infection (natural or experimental), age, sample numbers, dose, route of inoculation, viral replication, detection method, clinical symptoms and transmission. Fifty-four studies were included, of which 34 were conducted on animal reservoirs (naturally or experimentally infected), and 20 involved models for testing vaccines and therapeutics. Our search revealed that Rousettus aegyptiacus (fruit bats), pangolins, felines, mink, ferrets and rabbits were all susceptible to SARS-CoV-2, while dogs were weakly susceptible and pigs, poultry, and tree shrews were not. In addition, virus replication in mice, mink, hamsters and ferrets resembled subclinical human infection, so these animals might serve as useful models for future studies to evaluate vaccines or antiviral agents and to study host-pathogen interactions. Our review comprehensively summarized current evidence on SARS-CoV-2 infection in animals and their usefulness as models for studying vaccines and antiviral drugs. Our findings may direct future studies for vaccine development, antiviral drugs and therapeutic agents to manage SARS-CoV-2-caused diseases.
目前,严重急性呼吸系统综合症冠状病毒 2 型(SARS-CoV-2)的爆发在全球范围内迅速蔓延,引起了全球的严重关注。动物宿主在疾病传播中所起的作用仍未得到充分研究,研究人员希望找到合适的动物模型,用于基础研究和药物发现。在这项系统综述中,我们旨在编译和讨论所有描述 SARS-CoV-2 实验或自然感染的文章,从 2019 年 12 月病毒首次发现到 2020 年 10 月。我们系统地搜索了四个数据库(Scopus、PubMed、Science Direct 和 Web of Science)。从纳入的研究中提取了以下数据:感染类型(自然或实验)、年龄、样本数量、剂量、接种途径、病毒复制、检测方法、临床症状和传播。共纳入 54 项研究,其中 34 项在动物宿主(自然或实验感染)上进行,20 项涉及疫苗和治疗剂的测试模型。我们的搜索结果表明,埃及果蝠、穿山甲、猫科动物、水貂、雪貂和兔类均易感染 SARS-CoV-2,而犬类易感性较弱,猪、禽类和树鼩不易感染。此外,小鼠、水貂、仓鼠和雪貂中的病毒复制类似于亚临床人类感染,因此这些动物可能成为未来研究评估疫苗或抗病毒药物以及研究宿主-病原体相互作用的有用模型。本综述全面总结了目前关于 SARS-CoV-2 感染动物及其作为疫苗和抗病毒药物研究模型的有用性的证据。我们的发现可能为未来的疫苗开发、抗病毒药物和治疗剂的研究指明方向,以管理 SARS-CoV-2 引起的疾病。